Loading...
HomeMy WebLinkAboutRES 21-203RESOLUTION NO. 21-203 BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF BEAUMONT: THAT the City Manager, or his designee, be and they are hereby authorized to execute all documents necessary, specifically a Program Funded State and Local Task Force Agreement, between the Beaumont Police Department and the United States Department of Justice, Drug Enforcement Administration (DEA) for the purpose of detailing one (1) experienced officer to the Beaumont Task Force for a period of not less than two (2) years and apply for federal reimbursement of overtime hours worked by the officer. The Agreement is substantially in the form attached hereto as Exhibit "A" and made a part hereof for all purposes. The meeting at which this resolution was approved was in all things conducted in strict compliance with the Texas Open Meetings Act, Texas Government Code, Chapter 551 PASSED BY THE CITY COUNCIL of the City of Beaumont this the 24th day of August, 2021. yq � `%,I - Mayor Robin Mouton - s w/ PROGRAM FUNDED STATE AND LOCAL TASK FORCE AGREEMENT This agreement is made this 1" day of October 2021, between the United States Department of Justice, Drug Enforcement Administration (hereinafter "DEA"),i and the Beaumont Police Department (hereinafter "BPD"), ORI Number TX1230100. The DEA is authorized to enter into this cooperative agreement concerning the use and abuse of controlled substances under the provisions of21 U.S.C. § 873. Whereas there is evidence that trafficking in narcotics and dangerous drugs exists in the Beaumont, Texas, area and that such illegal activity has a substantial and detrimental effect on the health and general welfare of the people of Texas, the parties hereto agree to the following: 1. The Beaumont Task Force will perform the activities and duties described below: a. disrupt the illicit drug traffic in the Beaumont, Texas, area by immobilizing targeted violators and trafficking organizations; b. gather and report intelligence data relating to trafficking in narcotics and dangerous drugs; and c. conduct undercover operations where appropriate and engage in other traditional methods of investigation in order that the Task Force's activities will result in effective prosecution before the courts of the United States and the State of Texas. 2. To accomplish the objectives of the Beaumont Task Force, the BPD agrees to detail one experienced officer(s) to the Beaumont Task Force for a period of not less than two years. During this period of assignment, the BPD assigned officer(s) will be under the direct supervision and control of DEA supervisory personnel assigned to the Task Force. 3. The BPD officer(s) assigned to the Task Force shall adhere to all DEA policies and procedures. Failure to adhere to DEA policies and procedures shall be grounds for dismissal from the Task Force. 4. The BPD officer(s) assigned to the Task Force shall be deputized as Task Force Officer(s) of DEA pursuant to 21 USC 878. 5. To accomplish the objectives of the Beaumont Task Force, DEA will assign four Special Agents to the Task Force. DEA will also, subject to the availability of annually appropriated funds or any continuing resolution thereof, provide necessary funds and equipment to support the activities of the DEA Special Agents and BPD officer(s) to the Task Force. This support will include: office space, office supplies, travel funds, funds for the purchase of evidence and information, investigative equipment, training and other support items. 6. During the period of assignment to the Beaumont Task Force, the BPD will remain responsible for establishing the salary and benefits, including overtime, of the officer(s) assigned to the Task Page 1 of 3 SURGE EXHIBIT "A" Force and for making all payments due them. DEA will, subject to availability of funds, reimburse the BPD for overtime payment. Annual overtime for each state or local law enforcement officer is capped at the equivalent of 25% of a GS-12, Step 1, of the General Pay Scale for the Rest of United States. Reimbursement for all types of qualified expenses shall be contingent upon availability of funds and the submission of a proper request for reimbursement which shall be submitted monthly or quarterly on a fiscal year basis, and which provides the names of the investigators who incurred overtime for DEA during the invoiced period, the number of overtime hours incurred, the hourly regular and overtime rates in effect for each investigator, and the total cost for the invoiced period. Invoices must be submitted at least quarterly within 10 business days of the end of the invoiced period. Note: Task Force Officer's overtime "shall not include any costs for benefits, such as retirement, FICA, and other expenses." 7. In no event will the BPD charge any indirect cost rate to DEA for the administration or implementation of this agreement. 8. The BPD shall maintain on a current basis complete and accurate records and accounts of all obligations and expenditures of funds under this agreement in accordance with generally accepted accounting principles and instructions provided by DEA to facilitate on -site inspection and auditing of such records and accounts. 9. The BPD shall permit and have readily available for examination and auditing by DEA, the United States Department of Justice, the Comptroller General of the United States and any of their duly authorized agents and representatives, any and all records, documents, accounts, invoices, receipts or expenditures relating to this agreement. The BPD shall maintain all such reports and records until all litigation, claim, audits and examinations are completed and resolved or for a Period of six (6) years after termination of this agreement, whichever is sooner. 10. The BPD shall comply with Title VI of the Civil Rights Act of 1964, Section 504 of the Rehabilitation Act of 1973, the Age Discrimination Act of 1975, as amended, and all requirements imposed by or pursuant to the regulations of the United States Department of Justice implementing those laws, 28 C.F.R. Part 42, Subparts C. F, G, H and 1. 11. The BPD agrees that an authorized officer(s) or employee will execute and return to DEA the attached OJP Form 4061/6, Certification Regarding Lobbying; Debarment, Suspension and Other Responsibility Matters; and Drug -Free Workplace Requirements. The BPD acknowledges that this agreement will not take effect and no federal funds wilt be awarded to the BPD by DEA until the completed certification is received. 12. When issuing statements, press releases requests for proposals, bid solicitations and other documents describing programs or projects funded in whole or part with federal money, the BPD shall clearly state: (1) percentage of the total cost of the program or project which will be financed with federal money and (2) the dollar amount of federal funds for the program or project. 13. The term of this agreement shall be effective from the date in paragraph number one until September 30, 2022. This agreement may be terminated by either party on 30 days advance written notice. Billing for all outstanding obligations must be received by DEA within 90 days of the date Page 2 of 3 SURGE of termination of this agreement. DEA will be responsible only for obligations incurred by BPD during the term of this agreement. For the Drug Enforcement Administration: Daniel C. Comeaux Special Agent in Charge For the Beaumont Police Department James P. Singletary Chief of Police Page 3 of 3 Date: Date: SU E U.S. DEPARTMENT OF JUSTICE OFFICE OF JUSTICE PROGRAMS OFFICE OF THE COMPTROLLER CERTIFICATIONS REGARDING LOBBYING; DEBARMENT, SUSPENSION AND OTHER RESPONSIBILITY MATTERS; AND DRUG -FREE WORKPLACE REQUIREMENTS Applicants should refer to the regulations cited below to determine the certification to which they are required to attest. Applicants should also review the Instructions for certification Included In the regulations before completing this form. Signature of this form provides for compliance with certification requirements under 28 CFR Part 69, "New Restrictions on Lobbying" and 26 CFR Part 67, 'Government -wide Debarment and Suspension (Nonprc-curement) and Government -wide Requirements for Drug -Free Workplace (Grants).' The certifications shall be treated as a material representation of fact upon which reliance will be placed when the Department of Justice determines to award the covered transaction, grant, or cooperative agreement. 1. LOBBYING As required by Section 1352, Tille 31 of the U.S. Code, and implemented.128 CFR Pad 69. for persons entering into B grant or cooperalive agreement over $100,000, as defined at 26 CFR Pad 69, the applicant Defined that: (a) No Federal appropriated funds have been paid or will be paid, by or on behalf of the undersigned, to any parson for in. fluencing or attempting to influence an officer or employee of any agency, a Member of Congress, an officer or employe. of Congress, or an employee of a Member of Congress in con- nection with the making of any Federal grant, the entering into of any cooperative agreement, and the extension, continuation, renewal, amendment, or modification of any Fetlaral grant or cooperative agreement: IS) If any funds other than Federal appoint aled funds have been paid or will be paid to any pis non for influencing or at- tempting to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with this Federal grant or cooperative agreement, the undersigned shall complete and submit Standard Form - LLL,'Disclosure of Lobbying Activities," in accordance with its Instructions; (c) The undersigned shall require that the language of this cer- tification be included in the award documents for all subawards at all tiers (including subgrents, contracts under giants and cooperative agreement, and subcontracts) and that all sub - recipients shall certify and disclose accordingly. 2. DEBARMENT, SUSPENSION, AND OTHER RESPONSIBILITY MATTERS (DIRECT RECIPIENT) As required by Executive Order 12549. Debarment and Suspension, and Implemented at 28 CFR Part 67, for prospec- tive participants in primary covered transactions. ea defined at 28 CFR Part 67. Section 61.510— A_ The applicant certifies that it and its principals: (a) Are not presently debarred, suspended, proposed for debar- ment, declared 'Ineligible, sentenced to a denial of Federal benefits by a Slate or Federal court, or voluntarily excluded from covered transactions by any Federal department or agency; (b) Have not within a three-year period preceding this applica. tion been convicted of or had a civil judgment rendered egai nsl them for commission of fraud or a criminal offense in connec- tion with obtaining, attempting to obtain, or performing a public (Federal. State, or local) transaction or contract under public transaction; violation of Federal or State antitrust statutes or commission of embezzlement, iheft, longer,, bribery, falsiflcatlon or destruction of records, making false statements, or receiving stolen properly; (c) Are not presently indicted for or otherwise criminally or Civilly charged by a governmental entity (Federal, Stele, or local) with Commission of any of the offenses enumerated in paragraph If )(Id of this cenificalion; and (it) Have not within a three-year period preceding this applica. tion had one or more public transactions (Federal, State, or local) terminated for cause or default; and B- Where the applicant is unable to certify to any of the statements in this certification, he or she shall attach an explanation l0 this application. 3. DRUG -FREE WORKPLACE (GRANTEES OTHER THAN INDIVIDUALS) As required by the Drug -Free Workplace Act of 1988. and implemented at 28 CFR Part 67, Subpart F, for grantees, as defined at 28 CFR Pan 67 Sections 67.615 and 61.620— A. The applicant certifies that It will or will continue to provide a drug -free workplace by (a) Publishing a statement notifying employees that the unlawful manufaclum,distribution, dispensing, possession, or use of a controlled substance is prohibited In this grantee's workplace and specifying the actions that will be taken against employees for violation of such prohibition; (b) Establishing an on -going drug -free awareness program to inform employees about— (1) The dangers of drug abuse in the workplace; (2) The grantee's policy of maintaining a drug -free workplace; (3) Any available drug counseling, rehabilitation, and employee Safi programs) and (4) The penalties that may be imposed upon employees for drug abuse violations occurring in the workplace; (c) Making it a requirement that each employee to be engaged in the performance of the grant be given a copy of the state- ment required by paragraph (a); (d) Notifying the employee in the statement required by para- graph (a) that, as a condition of employment under the grant, the employee will- 01 FORM 406116 (3 el ) REPLACES OJP FORMS 406112, 406113 AND 40014 WHICH ARE OBSOLETE. (1)Abide by the terms of the statement; and (2) Notify the employer in writing of his or her conviction for a violation of a criminal drug statute occurring in the workplace no later than five calendar days after such conviction', (a) Notifying the agency, in writing, with In 10 calendar days after receiving notice under subparagraph (d)(2) from an employee or otherwise receiving actual notice of such convic-lion Employers of convicted employees must provide notice, Including position title, to: Department of Justice, Office of Justice Programs, ATTN: Control Desk. 633 Indiana Avenue, N W., Washington, D.C. 20531, Notice shall Include the loan- tificatlon numbers) of each affected grant; (I) Taking one of the fallowing actions, within 30 calendar days of recelving notice under subparagraph (d)(2), with respect to any employee who Is so convicted— (1) Taking appropriate personnel action against such an employee, up to and Including termination, consistent with the requirements of the Rehabilitation Act of 1973. as amended; or (2) Requiring such employee to participate satisfactorily in a drug abuse assistance or rehabilitation program approved for such purposes by a Federal. State, or local health, law enforce- ment, or other appropriate agency: (g) Making a good faith effort to continue to maintain a drug - free workplace through implementation of paragraphs (a), (b), (o), (d), (a), and (1). B. The grantee may insert in the space provided below the sites) for the performance of work done In connection with the specific grant: Place of Performance (Street address, city, county, state, zip code) Check ❑ if there are workplaces on file that are not indentified here. Section 67, 630 of the regulations provides that a grantee that is a State may elect to make one certification in each Federal fiscal year A copy of which should be included with each ap- plication for Department of Justice funding. States and Stale agencies may elect to use OJP Form 40619, Check ❑ if the State has elected to complete OJP Form 406117. DRUG -FREE WORKPLACE (GRANTEES WHO ARE INDIVIDUALS) As required by the Drug -Free Workplace Act of 1988, and implemented at 28 CFR Part 67, Subpart F, for grantees, as defined at 26 CFR Part 67; Sections 67.615 and 67.620— A_ As a condition of the grant, I certify that I will not engage In the unlawful manufacture, distribution, dispensing, posses- sion, or use of a controlled substance in conducting any activity with the grant and B. If convicted of a criminal drug offense resulting from a violation occurring during the conduct of any grant activity. I will report the conviction, in writing, within 10 calendar days of the conviction, to: Department of Justice, Office of Justice Programs, ATTN: Control Desk, 810 Seventh Street NW„ Washington, DC 20531, As the duly authorized representative of the applicant, I hereby certify that the applicant will comply with the above certifications. 1. Grantee Name and Address .,- --E_,.-._._sa 2. Application Number endlor Project Name NIA 4, Typed Name and Title of Authorized Representative S. Signature 3. Grantee IRSNendor Number N/A 6. Data us. m..,,m.vaw,s„v Dirac ices- aosami "